EUVIMEDEUVIMED entdecken
EditorialKommentar

Editorial Comment to Novel quantitative software for automatically excluding red bone marrow on whole‐body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study

Toshiki Kijima iD

International Journal of Urology · 2023

DOI: 10.1111/iju.15147 ↗

Kurz gefasst

Editorial in der Zeitschrift International Journal of Urology, 2023. Verfasst von Toshiki Kijima. Beteiligte Einrichtung: Department of Urology, Dokkyo Medical University, Shimotsuga, Tochigi, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Bone Neoplasms. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBone NeoplasmsMaleHumansMagnetic Resonance ImagingPilot ProjectsBone MarrowWhole Body ImagingSoftware

Autor:innen und Institutionen

  • Department of Urology, Dokkyo Medical University, Shimotsuga, Tochigi, Japan.

ORCID-Profile: Toshiki Kijima

Zitieren

APA

Kijima, T. (2023). Editorial Comment to Novel quantitative software for automatically excluding red bone marrow on whole‐body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study. International Journal of Urology. https://doi.org/10.1111/iju.15147

Vancouver

Kijima T. Editorial Comment to Novel quantitative software for automatically excluding red bone marrow on whole‐body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study. International Journal of Urology. 2023. doi:10.1111/iju.15147

BibTeX
@article{Kijima2023,
  author = {Kijima, Toshiki},
  title = {Editorial Comment to Novel quantitative software for automatically excluding red bone marrow on whole‐body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study},
  journal = {International Journal of Urology},
  year = {2023},
  doi = {10.1111/iju.15147}
}
Kostenlos starten →